The Experts below are selected from a list of 720 Experts worldwide ranked by ideXlab platform

M G Collis - One of the best experts on this subject based on the ideXlab platform.

  • pharmacokinetics of 8 Phenyltheophylline in the rat
    Journal of Pharmacy and Pharmacology, 2011
    Co-Authors: A Wormald, M. S. Yates, Christopher J. Bowmer, M G Collis
    Abstract:

    The pharmacokinetics of the adenosine antagonist 8-Phenyltheophylline (8-PT) have been investigated in the rat. After intravenous administration to male rats with normal renal function, 8-PT was rapidly cleared from plasma with a t1/2 of about 14 min. Its apparent volume of distribution was some 76 mL/100 g and plasma clearance was 3.5 mL min-1/100 g. Injection via the carotid artery did not alter the kinetics of 8-PT, but when given through the portal vein a first-pass effect was observed. Moreover, 8-PT could not be detected in plasma following intraperitoneal injection. The kinetics of 8-PT were not altered in male rats with acute renal failure and no difference was noted between male and female animals with respect to the kinetics of 8-PT following intravenous injection. It is concluded that the pharmacokinetic properties of 8-PT are likely to complicate its use in-vivo.

  • comparison of the potency of 8 Phenyltheophylline as an antagonist at a1 and a2 adenosine receptors in atria and aorta from the guinea pig
    Journal of Pharmacy and Pharmacology, 2011
    Co-Authors: M G Collis, D B Palmer, V L Saville
    Abstract:

    The potency of 8Phenyltheophylline as an antagonist at A, adenosine receptors in guinea-pig atria and at A2 adenosine receptors in the guinea-pig aorta has been investigated. 8-Phenyltheophylfine was an apparently competitive antagonist of the negative chronotropic effect of adenosine, 2-chloroadenosine, L- N6 -phenyl-isopropyl adenosine (L-PIA) and 5′- N-ethylcarboxamide adenosine (NECA) on atria and of the relaxant effect of adenosine, 2−chloroadenosine and NECA on the aorta. The pA2 values for 8Phenyltheophylline ranged from 6.4 to 6.6 and were not significantly different, irrespective of the agonist or tissue used. These results indicate that 8Phenyltheophylline is a relatively potent antagonist at adenosine receptors but does not exhibit selectivity for either of the putative sub-types in isolated tissues.

  • amelioration of glycerol induced acute renal failure in the rat with 8 Phenyltheophylline timing of intervention
    Journal of Pharmacy and Pharmacology, 2011
    Co-Authors: Christopher J. Bowmer, M G Collis, M. S. Yates
    Abstract:

    The importance of timing and duration of 8-Phenyltheophylline (8-PT) administration in determining its beneficial action in glycerol-induced acute renal failure (ARF) was investigated by examining the effects of a single dose of 8-PT given immediately following (0 h) glycerol injection and at 1 and 3 h after glycerol injection. 8-PT when given at 0 h significantly lowered plasma urea and creatinine concentrations and significantly increased inulin clearance when compared both to untreated animals and those that received the vehicle for the drug. By contrast, 8-PT when administered at 1 h afforded no protective effect on renal function and, when injected at 3 h, the only significant effect was lowered plasma creatinine levels when compared to untreated rats; at this latter time it did not lower plasma urea levels or improve inulin clearance. None of the 8-PT injections attenuated the increase in kidney weight associated with ARF or reduced the kidney damage as assessed by histological examination. The results show that a single administration of 8-PT made immediately following glycerol injection can ameliorate the biochemical and functional indices of impaired renal function, but does not produce an improvement in kidney morphology.

M. S. Yates - One of the best experts on this subject based on the ideXlab platform.

  • pharmacokinetics of 8 Phenyltheophylline in the rat
    Journal of Pharmacy and Pharmacology, 2011
    Co-Authors: A Wormald, M. S. Yates, Christopher J. Bowmer, M G Collis
    Abstract:

    The pharmacokinetics of the adenosine antagonist 8-Phenyltheophylline (8-PT) have been investigated in the rat. After intravenous administration to male rats with normal renal function, 8-PT was rapidly cleared from plasma with a t1/2 of about 14 min. Its apparent volume of distribution was some 76 mL/100 g and plasma clearance was 3.5 mL min-1/100 g. Injection via the carotid artery did not alter the kinetics of 8-PT, but when given through the portal vein a first-pass effect was observed. Moreover, 8-PT could not be detected in plasma following intraperitoneal injection. The kinetics of 8-PT were not altered in male rats with acute renal failure and no difference was noted between male and female animals with respect to the kinetics of 8-PT following intravenous injection. It is concluded that the pharmacokinetic properties of 8-PT are likely to complicate its use in-vivo.

  • amelioration of glycerol induced acute renal failure in the rat with 8 Phenyltheophylline timing of intervention
    Journal of Pharmacy and Pharmacology, 2011
    Co-Authors: Christopher J. Bowmer, M G Collis, M. S. Yates
    Abstract:

    The importance of timing and duration of 8-Phenyltheophylline (8-PT) administration in determining its beneficial action in glycerol-induced acute renal failure (ARF) was investigated by examining the effects of a single dose of 8-PT given immediately following (0 h) glycerol injection and at 1 and 3 h after glycerol injection. 8-PT when given at 0 h significantly lowered plasma urea and creatinine concentrations and significantly increased inulin clearance when compared both to untreated animals and those that received the vehicle for the drug. By contrast, 8-PT when administered at 1 h afforded no protective effect on renal function and, when injected at 3 h, the only significant effect was lowered plasma creatinine levels when compared to untreated rats; at this latter time it did not lower plasma urea levels or improve inulin clearance. None of the 8-PT injections attenuated the increase in kidney weight associated with ARF or reduced the kidney damage as assessed by histological examination. The results show that a single administration of 8-PT made immediately following glycerol injection can ameliorate the biochemical and functional indices of impaired renal function, but does not produce an improvement in kidney morphology.

Christopher J. Bowmer - One of the best experts on this subject based on the ideXlab platform.

  • pharmacokinetics of 8 Phenyltheophylline in the rat
    Journal of Pharmacy and Pharmacology, 2011
    Co-Authors: A Wormald, M. S. Yates, Christopher J. Bowmer, M G Collis
    Abstract:

    The pharmacokinetics of the adenosine antagonist 8-Phenyltheophylline (8-PT) have been investigated in the rat. After intravenous administration to male rats with normal renal function, 8-PT was rapidly cleared from plasma with a t1/2 of about 14 min. Its apparent volume of distribution was some 76 mL/100 g and plasma clearance was 3.5 mL min-1/100 g. Injection via the carotid artery did not alter the kinetics of 8-PT, but when given through the portal vein a first-pass effect was observed. Moreover, 8-PT could not be detected in plasma following intraperitoneal injection. The kinetics of 8-PT were not altered in male rats with acute renal failure and no difference was noted between male and female animals with respect to the kinetics of 8-PT following intravenous injection. It is concluded that the pharmacokinetic properties of 8-PT are likely to complicate its use in-vivo.

  • amelioration of glycerol induced acute renal failure in the rat with 8 Phenyltheophylline timing of intervention
    Journal of Pharmacy and Pharmacology, 2011
    Co-Authors: Christopher J. Bowmer, M G Collis, M. S. Yates
    Abstract:

    The importance of timing and duration of 8-Phenyltheophylline (8-PT) administration in determining its beneficial action in glycerol-induced acute renal failure (ARF) was investigated by examining the effects of a single dose of 8-PT given immediately following (0 h) glycerol injection and at 1 and 3 h after glycerol injection. 8-PT when given at 0 h significantly lowered plasma urea and creatinine concentrations and significantly increased inulin clearance when compared both to untreated animals and those that received the vehicle for the drug. By contrast, 8-PT when administered at 1 h afforded no protective effect on renal function and, when injected at 3 h, the only significant effect was lowered plasma creatinine levels when compared to untreated rats; at this latter time it did not lower plasma urea levels or improve inulin clearance. None of the 8-PT injections attenuated the increase in kidney weight associated with ARF or reduced the kidney damage as assessed by histological examination. The results show that a single administration of 8-PT made immediately following glycerol injection can ameliorate the biochemical and functional indices of impaired renal function, but does not produce an improvement in kidney morphology.

Gareth A Edwards - One of the best experts on this subject based on the ideXlab platform.

  • activation of p1 and p2y purinoceptors by adp ribose in the guinea pig taenia coli but not of p2x purinoceptors in the vas deferens
    British Journal of Pharmacology, 1992
    Co-Authors: Charles H V Hoyle, Gareth A Edwards
    Abstract:

    1. The activity of adenosine 5'-diphosphoribose (ADP-ribose), a ribosylated purine nucleotide, was investigated on the carbachol-contracted taenia coli, a tissue possessing P1- (A2) and P2Y-purinoceptors and on the guinea-pig vas deferens which possesses P2X-purinoceptors. 2. In the vas deferens, where ATP (1 microM-1 mM) produced concentration-dependent contractions, ADP-ribose was without effect at concentrations up to 1 mM. 3. In the taenia coli, ADP-ribose (0.1 microM-1 mM) produced concentration-dependent relaxations with a potency similar to that of adenosine, but less than that of ATP. The pD2 values for ADP-ribose, adenosine and ATP were 4.5 +/- 0.07 (27), 4.4 +/- 0.10 (9) and 5.5 +/- 0.14 (21), respectively. The time-course of the relaxations elicited by ADP-ribose was found to be significantly longer than that for ATP and significantly shorter than that for adenosine. 4. The P1-purinoceptor antagonist, 8-Phenyltheophylline (5 microM), produced parallel rightward shifts in the concentration-response curves of the relaxations of the taenia coli elicited by ADP-ribose and adenosine but not ATP. 5. Dipyridamole (0.3 microM), a purine nucleoside uptake inhibitor, potentiated the responses to adenosine and ADP-ribose in the taenia coli. These potentiations were sensitive to 8-Phenyltheophylline (5 microM). 6. Reactive blue 2, a P2Y-purinoceptor antagonist, antagonized the inhibitory responses of ADP-ribose and ATP in the taenia coli, without significantly altering the inhibitory responses of either adenosine or noradrenaline.(ABSTRACT TRUNCATED AT 250 WORDS)

V L Saville - One of the best experts on this subject based on the ideXlab platform.

  • comparison of the potency of 8 Phenyltheophylline as an antagonist at a1 and a2 adenosine receptors in atria and aorta from the guinea pig
    Journal of Pharmacy and Pharmacology, 2011
    Co-Authors: M G Collis, D B Palmer, V L Saville
    Abstract:

    The potency of 8Phenyltheophylline as an antagonist at A, adenosine receptors in guinea-pig atria and at A2 adenosine receptors in the guinea-pig aorta has been investigated. 8-Phenyltheophylfine was an apparently competitive antagonist of the negative chronotropic effect of adenosine, 2-chloroadenosine, L- N6 -phenyl-isopropyl adenosine (L-PIA) and 5′- N-ethylcarboxamide adenosine (NECA) on atria and of the relaxant effect of adenosine, 2−chloroadenosine and NECA on the aorta. The pA2 values for 8Phenyltheophylline ranged from 6.4 to 6.6 and were not significantly different, irrespective of the agonist or tissue used. These results indicate that 8Phenyltheophylline is a relatively potent antagonist at adenosine receptors but does not exhibit selectivity for either of the putative sub-types in isolated tissues.